Please login to the form below

Not currently logged in
Email:
Password:

Kaletra

This page shows the latest Kaletra news and features for those working in and with pharma, biotech and healthcare.

AbbVie, Amgen and Takeda team up for joint COVID-19 trial

AbbVie, Amgen and Takeda team up for joint COVID-19 trial

Unfortunately, not all efforts to repurpose drugs have proved successful, with AbbVie’s Kaletra HIV treatment (lopinavir/ritonavir) failing to show efficacy against the virus.

Latest news

More from news
Approximately 2 fully matching, plus 27 partially matching documents found.

Latest Intelligence

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    19. Kaletra combines two antivirals, lopinavir and ritonavir, and is already approved for use as a treatment for HIV. ... who].were late in infection and already had considerable tissue damage”. However, the study also found that Kaletra is unable to

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...

Infographics